Vasundhara Rasayans Ltd

Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging price performance and a competitive peer landscape. Investors are advised to carefully analyse the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios in relation to historical averages and sector benchmarks to assess its price attractiveness.

Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.101.15 today, marking a significant decline amid a volatile trading session. The stock’s performance continues to lag behind broader market indices and sector peers, reflecting ongoing pressures on its financial metrics and market positioning.

Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from fair to attractive territory. Despite a challenging market environment and significant share price declines, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for value investors seeking opportunities in the sector.

Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.106 today, marking a significant downturn in its stock performance amid broader market weakness and company-specific pressures.

Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with the latest insights into its performance and outlook.

Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.112.05 today, marking a significant milestone in its ongoing price decline. Despite a volatile trading session, the stock remains below all key moving averages, reflecting persistent downward pressure amid subdued financial performance.

Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.120 today, marking a significant decline amid a series of consecutive losses. The stock has underperformed both its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics.

Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.125 today, marking a significant decline amid a sustained downward trend. The stock’s performance over the past year has been notably weak, reflecting broader challenges within the company’s financial metrics and market positioning.

Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.125.1 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics.

Shares of Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, declined to a fresh 52-week low of Rs.128.3 today, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent pressures on the company’s financial performance and market valuation amid broader sectoral and company-specific factors.

Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.128.6 today, marking a significant decline amid a broader market downturn and persistent underperformance relative to its sector and benchmark indices.

Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 December 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 18 February 2026, providing investors with the latest insights into its performance and outlook.

Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change, coupled with a significant downgrade in its Mojo Grade to Strong Sell, underscores growing investor caution amid a challenging market environment and relative underperformance against benchmarks and peers.

Vasundhara Rasayans Limited, the Hyderabad-based pharmaceutical ingredients manufacturer, reported a remarkable 261.40% surge in net profit to ₹2.06 crores for Q2 FY26, up from ₹0.57 crores in the previous quarter. However, the impressive bottom-line performance belies concerning top-line trends, with revenues declining 9.82% year-on-year to ₹8.82 crores. The stock, with a market capitalisation of ₹50.00 crores, closed at ₹150.00 on February 10, 2026, down 4.61% on the day, reflecting investor concerns about the company's ability to sustain growth momentum.

Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date perspective on its performance and outlook.